InDex Pharmaceuticals Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

InDex Pharmaceuticals General Information

Description

Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Berzelius väg 13
  • 171 65 Solna
  • Sweden
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Berzelius väg 13
  • 171 65 Solna
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InDex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 10-Jun-2024 Completed Profitable
13. PIPE 19-Sep-2019 Completed Profitable
12. PIPE 29-Oct-2018 Completed Profitable
11. Grant 23-Mar-2018 Completed Startup
10. PIPE 01-Jan-2018 Completed Profitable
9. IPO 11-Oct-2016 Completed Profitable
8. Grant 23-May-2016 Completed Profitable
7. Later Stage VC 25-Feb-2014 Completed Generating Revenue
6. Later Stage VC 21-Jan-2011 $11.1M $18.8M Completed Generating Revenue
5. Early Stage VC 26-May-2004 $7.73M Completed Startup
To view InDex Pharmaceuticals’s complete valuation and funding history, request access »

InDex Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment opti
Drug Discovery
Solna, Sweden
7 As of 2018

San Diego, CA
 

Lund, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

InDex Pharmaceuticals Competitors (66)

One of InDex Pharmaceuticals’s 66 competitors is ACADIA Pharmaceuticals, a Formerly VC-backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACADIA Pharmaceuticals Formerly VC-backed San Diego, CA
Hansa Biopharma Corporation Lund, Sweden
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Gilead Formerly VC-backed Foster City, CA
Swedish Orphan Biovitrum Formerly VC-backed Stockholm, Sweden
You’re viewing 5 of 66 competitors. Get the full list »

InDex Pharmaceuticals Patents

InDex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022344527-A1 Enema formulation Inactive 09-Sep-2021
AU-2022344527-A9 Enema formulation Inactive 09-Sep-2021
CA-3209396-A1 Enema formulation Pending 09-Sep-2021
EP-4147688-A1 Enema formulation Inactive 09-Sep-2021
EP-4167962-A1 Enema formulation Active 09-Sep-2021 A61K9/0031
To view InDex Pharmaceuticals’s complete patent history, request access »

InDex Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

InDex Pharmaceuticals Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
CapMan Real Estate Minority
Angel (individual) Minority
Fjärde AP-fonden Limited Partner Minority
GZ Group Venture Capital Minority
You’re viewing 5 of 14 investors. Get the full list »

InDex Pharmaceuticals Acquisitions (1)

InDex Pharmaceuticals’s most recent deal was a Reverse Merger with Flerie. The deal was made on 10-Jun-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Flerie 10-Jun-2024 Reverse Merger Private Equity
To view InDex Pharmaceuticals’s complete acquisitions history, request access »

InDex Pharmaceuticals FAQs

  • When was InDex Pharmaceuticals founded?

    InDex Pharmaceuticals was founded in 2000.

  • Where is InDex Pharmaceuticals headquartered?

    InDex Pharmaceuticals is headquartered in Solna, Sweden.

  • What is the size of InDex Pharmaceuticals?

    InDex Pharmaceuticals has 7 total employees.

  • What industry is InDex Pharmaceuticals in?

    InDex Pharmaceuticals’s primary industry is Drug Discovery.

  • Is InDex Pharmaceuticals a private or public company?

    InDex Pharmaceuticals is a Private company.

  • What is InDex Pharmaceuticals’s current revenue?

    The current revenue for InDex Pharmaceuticals is .

  • How much funding has InDex Pharmaceuticals raised over time?

    InDex Pharmaceuticals has raised $86.5M.

  • Who are InDex Pharmaceuticals’s investors?

    , CapMan, , Fjärde AP-fonden, and GZ Group are 5 of 14 investors who have invested in InDex Pharmaceuticals.

  • Who are InDex Pharmaceuticals’s competitors?

    ACADIA Pharmaceuticals, Hansa Biopharma, Alnylam Pharmaceuticals, Gilead, and Swedish Orphan Biovitrum are some of the 66 competitors of InDex Pharmaceuticals.

  • When was InDex Pharmaceuticals acquired?

    InDex Pharmaceuticals was acquired on 10-Jun-2024.

  • Who acquired InDex Pharmaceuticals?

    InDex Pharmaceuticals was acquired by Flerie.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process